Trxade Group Inc (MEDS) — Capital Reinvestment Ratio
Trxade Group Inc (MEDS) has a Capital Reinvestment Ratio of 0.16x as of June 2023, meaning it reinvests 0% of its operating cash flow ($328.57K) in capital expenditures ($51.80K). See MEDS cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Trxade Group Inc Capital Reinvestment Ratio (2017–2019)
This chart tracks Trxade Group Inc's Capital Reinvestment Ratio across 3 annual periods. See how financially flexible is Trxade Group Inc to measure the company's free cash flow as a share of total liabilities.
Annual Capital Reinvestment Ratio for Trxade Group Inc (2017–2019)
Year-by-year Capital Reinvestment Ratio for Trxade Group Inc from 2017 to 2019. For the full cash flow conversion analysis, see MEDS cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.58x | $141.78K | $82.25K | ▲ +957.0% |
| 2018 | 0.05x | $273.39K | $15.01K | ▼ -37.2% |
| 2017 | 0.09x | $171.67K | $15.01K | — |